DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP in Canada?
Yes. DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP has an active shortage reported to Health Canada (last updated October 27, 2026).
Why is DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP not available?
The reason the manufacturer reported: Demand increase for the drug.
When will DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP be available again?
The manufacturer's estimated resolution date is November 13, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML
SANDOZ CANADA INCORPORATED
MAXIDEX
NOVARTIS PHARMACEUTICALS CANADA INC
DEXAMETHASONE
PHARMA STULLN INC.
PMS-DEXAMETHASONE
PHARMASCIENCE INC
DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP
STERIMAX INC
PMS-DEXAMETHASONE ELIXIR
PHARMASCIENCE INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.
Estimated Resolution
2026-11-13
~1 day remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
00874582
Strength
10MG
Dosage Form
LIQUID
Route
INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR
Active Ingredient
DEXAMETHASONE
Tier
Unrated
Last Updated
2026-10-27
Reason for Shortage
Demand increase for the drug.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759